Show simple item record

dc.contributor.authorDandah, Osama M.M.*
dc.contributor.authorNajafzadeh, Mojgan*
dc.contributor.authorIsreb, Mohammad*
dc.contributor.authorLinforth, R.*
dc.contributor.authorTait, C.*
dc.contributor.authorBaumgartner, Adolf*
dc.contributor.authorAnderson, Diana*
dc.date.accessioned2018-01-31T11:50:25Z
dc.date.available2018-01-31T11:50:25Z
dc.date.issued2018-02
dc.identifier.citationDandah O, Najafzadeh M, Isreb M et al (2017) Aspirin and ibuprofen, in bulk and nanoforms: Effects on DNA damage in peripheral lymphocytes from breast cancer patients and healthy individuals. Mutation Research/Genetic Toxicology and Environmental Mutagenesis. 826: 41-46.
dc.identifier.urihttp://hdl.handle.net/10454/14760
dc.descriptionYes
dc.description.abstractRegular use of non-steroidal anti-inflammatory drugs (NSAIDs) may be protective against tumours, including breast cancer. We have studied the effects of ibuprofen and aspirin on DNA damage in lymphocytes obtained from breast cancer patients and healthy female controls. Both nanoparticle (NPs) and bulk formulations were used in the comet and micronucleus (MN) assays. Non-toxic doses (250 ng/ml ibuprofen; 500 ng/ml aspirin) were tested. Aspirin, both bulk and nano formulations, significantly reduced DNA damage measured with the comet and micronucleus assays; the nano formulation was more effective. Ibuprofen was not effective in the comet assay but showed a significant reduction in MN frequency, with the nano formulation being more effective. NPs may have better penetration through the nuclear membrane relative to the bulk formulation. NSAIDs such as aspirin and ibuprofen may have a promising role in cancer prevention and treatment.
dc.description.sponsorshipLIBYAN GOVERNMENT
dc.language.isoen
dc.rights© 2017 Elsevier. Reproduced in accordance with the publisher's self-archiving policy. This manuscript version is made available under the CC-BY-NC-ND 4.0 license.
dc.subjectDNA damage
dc.subjectComet assay
dc.subjectLymphocytes
dc.subjectNanoparticles
dc.subjectAspirin
dc.subjectIbuprofen
dc.subjectBreast cancer
dc.titleAspirin and ibuprofen, in bulk and nanoforms: effects on DNA damage in peripheral lymphocytes from breast cancer patients and healthy individuals
dc.status.refereedYes
dc.date.application2017-12-24
dc.typeArticle
dc.type.versionAccepted manuscript
dc.identifier.doihttps://doi.org/10.1016/j.mrgentox.2017.12.001
dc.rights.licenseCC-BY-NC-ND
dc.openaccess.statusopenAccess
dc.date.accepted2017-12-07


Item file(s)

Thumbnail
Name:
paper 1 final version.docx
Size:
229.7Kb
Format:
Unknown
Description:
To keep suppressed
Thumbnail
Name:
Dandah_et_al.pdf
Size:
411.9Kb
Format:
PDF
Description:
To keep suppressed
Thumbnail
Name:
Dandah_et_al_final.pdf
Size:
508.0Kb
Format:
PDF

This item appears in the following Collection(s)

Show simple item record